Showing results (1511-1520 of 2,335) with videos related to
Sort By:
Pageof 234
Movement Disorders : Official Journal of the Movement Disorder Society|December 31, 2013
Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutationMadeleine E Sharp, Karen S Marder, Lucien Côté, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 25, 2025
Depressive Symptoms Correlate With Tau Accumulation Rates in Amyloid Positive AdultsDaniel Talmasov, Aubrey S Johnson, Patrick J Brown, et al.Journal of Genetic Counseling|June 11, 2013
Knowledge of and interest in genetic results among Parkinson disease patients and caregiversKarina Sakanaka, Cheryl H Waters, Oren A Levy, et al.Psychological Medicine|January 16, 2019
Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigmAmanda McCleery, Daniel H Mathalon, Jonathan K Wynn, et al.Clinical Nuclear Medicine|October 24, 2002
Evaluation of active bleeding into hematomas by technetium-99m red blood cell scintigraphy before angiographyMark W Wilson, Nicholas Fidelman, Robert J Lull, et al.CNS Spectrums|May 19, 2020
A long-term, open-label study of valbenazine for tardive dyskinesiaJean-Pierre Lindenmayer, Cherian Verghese, Stephen R Marder, et al.AIDS Patient Care and Stds|August 1, 1996
Primary care physicians and their HIV prevention practicesS H Kerr, R O Valdiserri, J Loft, et al.Neurology|March 26, 2003
Predictors of nursing home placement in Huntington diseaseV L Wheelock, T Tempkin, K Marder, et al.Journal of Neurology|May 18, 2007
The effect of age of onset of PD on risk of dementiaD Aarsland, J T Kvaløy, K Andersen, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Meta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neurolepticsP Bech, J C Peuskens, S R Marder, et al.Pageof 234